
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $769.2M | $862.9M | $727.7M | $686.7M | $683M | |
Revenue Growth (YoY) | 4.66% | 12.19% | -15.68% | -5.63% | -0.54% | |
Cost of Revenues | $495.2M | $559.6M | $467.3M | $432M | $422.2M | |
Gross Profit | $274M | $303.3M | $260.3M | $254.6M | $260.7M | |
Gross Profit Margin | 35.62% | 35.15% | 35.77% | 37.08% | 38.17% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $228.7M | $237.2M | $229.5M | $221.8M | $233.6M | |
Other Inc / (Exp) | -$22.5M | -$13.7M | $551K | -$594K | -$14.6M | |
Operating Expenses | $228.7M | $237.7M | $234.6M | $221.8M | $233.6M | |
Operating Income | $45.3M | $65.6M | $25.7M | $32.8M | $27.1M | |
Net Interest Expenses | $17.3M | $15.5M | $17.2M | $21.7M | $22.2M | |
EBT. Incl. Unusual Items | $5.5M | $36.4M | $9M | $10.5M | -$9.7M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $9.9M | $16.5M | $5.7M | $6.2M | $3.3M | |
Net Income to Company | -$3M | $20.8M | -$6.2M | -$8.4M | -$15.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | -$3M | $20.8M | -$6.2M | -$8.4M | -$15.2M | |
Basic EPS (Cont. Ops) | -$0.14 | $0.97 | -$0.29 | -$0.40 | -$0.71 | |
Diluted EPS (Cont. Ops) | -$0.14 | $0.94 | -$0.29 | -$0.40 | -$0.71 | |
Weighted Average Basic Share | $20.9M | $21.4M | $21.6M | $21.2M | $21.5M | |
Weighted Average Diluted Share | $20.9M | $22M | $21.6M | $21.2M | $21.5M | |
EBITDA | $47.5M | $74.4M | $45.8M | $51.8M | $34.8M | |
EBIT | $22.8M | $51.9M | $26.2M | $32.2M | $12.5M | |
Revenue (Reported) | $769.2M | $862.9M | $727.7M | $686.7M | $683M | |
Operating Income (Reported) | $45.3M | $65.6M | $25.7M | $32.8M | $27.1M | |
Operating Income (Adjusted) | $22.8M | $51.9M | $26.2M | $32.2M | $12.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $195.7M | $182.7M | $145.4M | $142.2M | $140.1M | |
Revenue Growth (YoY) | 34.87% | -6.61% | -20.4% | -2.2% | -1.52% | |
Cost of Revenues | $129.7M | $119.6M | $91.6M | $84.7M | $89.4M | |
Gross Profit | $66M | $63.1M | $53.8M | $57.5M | $50.6M | |
Gross Profit Margin | 33.73% | 34.52% | 37.02% | 40.46% | 36.15% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $56.8M | $58.7M | $54.8M | $55.7M | $49.5M | |
Other Inc / (Exp) | $498K | $1M | -$1.1M | -$174K | -$527K | |
Operating Expenses | $56.8M | $58.7M | $54.8M | $55.7M | $49.5M | |
Operating Income | $9.2M | $4.4M | -$950K | $1.8M | $1.1M | |
Net Interest Expenses | $4M | $3.8M | $5.3M | $5.6M | $4.9M | |
EBT. Incl. Unusual Items | $5.7M | $1.6M | -$7.4M | -$4M | -$4.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.4M | $1.7M | -$1.3M | $210K | -$142K | |
Net Income to Company | $3.1M | $380K | -$8.8M | -$6.3M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $3.1M | $380K | -$8.8M | -$6.3M | -$4.2M | |
Basic EPS (Cont. Ops) | $0.15 | $0.02 | -$0.41 | -$0.29 | -$0.19 | |
Diluted EPS (Cont. Ops) | $0.14 | $0.02 | -$0.41 | -$0.29 | -$0.19 | |
Weighted Average Basic Share | $21.1M | $21.8M | $21.2M | $21.4M | $21.6M | |
Weighted Average Diluted Share | $21.8M | $22.1M | $21.2M | $21.4M | $21.6M | |
EBITDA | $15.7M | $10.3M | $2.8M | $6.6M | $6.3M | |
EBIT | $9.7M | $5.4M | -$2M | $1.7M | $572K | |
Revenue (Reported) | $195.7M | $182.7M | $145.4M | $142.2M | $140.1M | |
Operating Income (Reported) | $9.2M | $4.4M | -$950K | $1.8M | $1.1M | |
Operating Income (Adjusted) | $9.7M | $5.4M | -$2M | $1.7M | $572K |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $819.8M | $850M | $690.4M | $683.5M | $680.8M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $532.7M | $549.6M | $439.3M | $425.1M | $427M | |
Gross Profit | $287.1M | $300.4M | $251.1M | $258.3M | $253.8M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $227.4M | $239.2M | $225.6M | $222.8M | $227.4M | |
Other Inc / (Exp) | $394K | -$13.1M | -$1.6M | $322K | -$15M | |
Operating Expenses | $227.4M | $239.7M | $230.7M | $222.8M | $227.4M | |
Operating Income | $59.7M | $60.7M | $20.4M | $35.6M | $26.4M | |
Net Interest Expenses | $16.6M | $15.3M | $18.8M | $22M | $21.5M | |
EBT. Incl. Unusual Items | $43.5M | $32.3M | $16K | $13.9M | -$10.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $16M | $15.8M | $2.7M | $7.8M | $3M | |
Net Income to Company | $28.2M | $18.1M | -$15.4M | -$5.9M | -$13.1M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $28.2M | $18.1M | -$15.4M | -$5.9M | -$13.1M | |
Basic EPS (Cont. Ops) | $1.35 | $0.84 | -$0.72 | -$0.28 | -$0.61 | |
Diluted EPS (Cont. Ops) | $1.30 | $0.82 | -$0.72 | -$0.28 | -$0.61 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $84.5M | $69M | $38.3M | $55.5M | $34.5M | |
EBIT | $60.1M | $47.6M | $18.8M | $35.9M | $11.4M | |
Revenue (Reported) | $819.8M | $850M | $690.4M | $683.5M | $680.8M | |
Operating Income (Reported) | $59.7M | $60.7M | $20.4M | $35.6M | $26.4M | |
Operating Income (Adjusted) | $60.1M | $47.6M | $18.8M | $35.9M | $11.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $195.7M | $182.7M | $145.4M | $142.2M | $140.1M | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $129.7M | $119.6M | $91.6M | $84.7M | $89.4M | |
Gross Profit | $66M | $63.1M | $53.8M | $57.5M | $50.6M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $56.8M | $58.7M | $54.8M | $55.7M | $49.5M | |
Other Inc / (Exp) | $498K | $1M | -$1.1M | -$174K | -$527K | |
Operating Expenses | $56.8M | $58.7M | $54.8M | $55.7M | $49.5M | |
Operating Income | $9.2M | $4.4M | -$950K | $1.8M | $1.1M | |
Net Interest Expenses | $4M | $3.8M | $5.3M | $5.6M | $4.9M | |
EBT. Incl. Unusual Items | $5.7M | $1.6M | -$7.4M | -$4M | -$4.3M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $2.4M | $1.7M | -$1.3M | $210K | -$142K | |
Net Income to Company | $3.1M | $380K | -$8.8M | -$6.3M | -$4.2M | |
Minority Interest in Earnings | -- | -- | -- | -- | -- | |
Net Income to Common Excl Extra Items | $3.1M | $380K | -$8.8M | -$6.3M | -$4.2M | |
Basic EPS (Cont. Ops) | $0.15 | $0.02 | -$0.41 | -$0.29 | -$0.19 | |
Diluted EPS (Cont. Ops) | $0.14 | $0.02 | -$0.41 | -$0.29 | -$0.19 | |
Weighted Average Basic Share | $21.1M | $21.8M | $21.2M | $21.4M | $21.6M | |
Weighted Average Diluted Share | $21.8M | $22.1M | $21.2M | $21.4M | $21.6M | |
EBITDA | $15.7M | $10.3M | $2.8M | $6.6M | $6.3M | |
EBIT | $9.7M | $5.4M | -$2M | $1.7M | $572K | |
Revenue (Reported) | $195.7M | $182.7M | $145.4M | $142.2M | $140.1M | |
Operating Income (Reported) | $9.2M | $4.4M | -$950K | $1.8M | $1.1M | |
Operating Income (Adjusted) | $9.7M | $5.4M | -$2M | $1.7M | $572K |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $36M | $28M | $23.6M | $16.2M | $2.9M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $170M | $175.1M | $141.2M | $155.2M | $156.7M | |
Inventory | $203.2M | $270.5M | $222.2M | $188.6M | $202.4M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $12.1M | $11.5M | $13.3M | $16.3M | $11.5M | |
Total Current Assets | $421.3M | $485.1M | $400.3M | $376.4M | $373.6M | |
Property Plant And Equipment | $119.7M | $107.2M | $92.9M | $86.7M | $74.6M | |
Long-Term Investments | $20M | $22.3M | $12.5M | $1.8M | -- | |
Goodwill | $30.3M | $30.3M | $33.2M | $33.2M | $33.2M | |
Other Intangibles | $213.8M | $182.4M | $180.7M | $165.9M | $150.3M | |
Other Long-Term Assets | $2.5M | $1.8M | $6.3M | $3.1M | $2.6M | |
Total Assets | $807.5M | $829.1M | $725.9M | $667.1M | $634.3M | |
Accounts Payable | $72.6M | $98.7M | $45M | $64.7M | $69.7M | |
Accrued Expenses | $19.4M | $31.6M | $19.5M | $25.7M | $21.2M | |
Current Portion Of Long-Term Debt | $17.7M | $5.8M | -- | $4.7M | $4.9M | |
Current Portion Of Capital Lease Obligations | $11.5M | $12.6M | $14M | $14.1M | $15.1M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $180.1M | $214.3M | $129.9M | $152M | $151.7M | |
Long-Term Debt | $266.3M | $241.9M | $253.3M | $196.2M | $173.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $577.3M | $573.4M | $485.8M | $436.3M | $404.4M | |
Common Stock | $218K | $220K | $218K | $218K | $222K | |
Other Common Equity Adj | -$39.2M | -$33.5M | -$35.9M | -$33.5M | -$18.3M | |
Common Equity | $230.1M | $255.6M | $240.1M | $230.9M | $229.9M | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $230.1M | $255.6M | $240.1M | $230.9M | $229.9M | |
Total Liabilities and Equity | $807.5M | $829.1M | $725.9M | $667.1M | $634.3M | |
Cash and Short Terms | $36M | $28M | $23.6M | $16.2M | $2.9M | |
Total Debt | $283.9M | $247.6M | $253.3M | $201M | $178.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $30.6M | $14.8M | $41M | $4.6M | $10.4M | |
Short Term Investments | -- | -- | -- | -- | -- | |
Accounts Receivable, Net | $131.3M | $117.3M | $124.7M | $113.6M | $105.7M | |
Inventory | $210.3M | $275.2M | $209.9M | $189.8M | $210.1M | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $10.1M | $13.2M | $11.4M | $13.9M | $14.5M | |
Total Current Assets | $382.3M | $420.6M | $388.3M | $322M | $340.6M | |
Property Plant And Equipment | $117M | $104.2M | $91.4M | $83M | $72.4M | |
Long-Term Investments | $21.1M | $22.8M | $10.4M | -- | -- | |
Goodwill | $30.3M | $33.4M | $33.2M | $33.2M | $33.2M | |
Other Intangibles | $209.7M | $191.9M | $177M | $162.1M | $146M | |
Other Long-Term Assets | $2.1M | $2.2M | $6M | $2.3M | $2.4M | |
Total Assets | $762.4M | $774.9M | $706.3M | $602.7M | $594.6M | |
Accounts Payable | $60.6M | $62.9M | $31M | $32.9M | $45.5M | |
Accrued Expenses | $74.6M | $85.4M | $68.1M | $64.7M | $57.8M | |
Current Portion Of Long-Term Debt | $11.6M | $1.1M | $7.6M | $10.7M | $4.9M | |
Current Portion Of Capital Lease Obligations | $12.1M | $13.6M | $13.7M | $14.3M | $15.4M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $165.9M | $164.8M | $120.4M | $123M | $124.2M | |
Long-Term Debt | $235M | $240.7M | $256.1M | $171.5M | $169M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $529M | $519.2M | $477.7M | $379M | $368.9M | |
Common Stock | $220K | $223K | $217K | $221K | $224K | |
Other Common Equity Adj | -$37.5M | -$33M | -$35.4M | -$33.2M | -$18M | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -- | -- | -- | -- | -- | |
Total Equity | $233.4M | $255.7M | $228.7M | $223.7M | $225.7M | |
Total Liabilities and Equity | $762.4M | $774.9M | $706.3M | $602.7M | $594.6M | |
Cash and Short Terms | $30.6M | $14.8M | $41M | $4.6M | $10.4M | |
Total Debt | $246.5M | $241.8M | $263.7M | $182.1M | $174M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | -$3M | $20.8M | -$6.2M | -$8.4M | -$15.2M | |
Depreciation & Amoritzation | $24.7M | $22.5M | $19.5M | $19.6M | $22.3M | |
Stock-Based Compensation | $6M | $5.2M | $3.8M | $3.7M | $3.9M | |
Change in Accounts Receivable | -$42.2M | -$5.5M | $33.9M | -$15M | -$3.2M | |
Change in Inventories | -$29M | -$67.5M | $47.4M | $35.4M | -$14.6M | |
Cash From Operations | $44.8M | $37M | $24.3M | $56.4M | $18.6M | |
Capital Expenditures | $2.1M | $4M | $3M | $2.8M | $2.2M | |
Cash Acquisitions | -- | $2.9M | -$18M | -- | -- | |
Cash From Investing | -$2.1M | -$1.1M | -$20.9M | -$2.8M | -$2.2M | |
Dividends Paid (Ex Special Dividend) | -$3.7M | -$3.8M | -$3.8M | -$3.7M | -$3.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $129.2M | $103.4M | $276.3M | $218.4M | $268.2M | |
Long-Term Debt Repaid | -$143.2M | -$141.3M | -$271.9M | -$263.1M | -$292.8M | |
Repurchase of Common Stock | -- | -- | -$6.3M | -$2.5M | -- | |
Other Financing Activities | -$658K | -$3.2M | -$2.1M | -$10.1M | -$1.1M | |
Cash From Financing | -$18.2M | -$44M | -$7.6M | -$61.1M | -$29.5M | |
Beginning Cash (CF) | $11.4M | $36M | $28M | $23.6M | $16.2M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $24.5M | -$8.1M | -$4.2M | -$7.4M | -$13.1M | |
Ending Cash (CF) | $36M | $28M | $23.6M | $16.2M | $2.9M | |
Levered Free Cash Flow | $42.7M | $33M | $21.3M | $53.6M | $16.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $3.1M | $380K | -$8.8M | -$6.3M | -$4.2M | |
Depreciation & Amoritzation | $6M | $4.9M | $4.9M | $4.9M | $5.7M | |
Stock-Based Compensation | $1.4M | $1.2M | $861K | $807K | $1.1M | |
Change in Accounts Receivable | $39M | $59.7M | $13.9M | $41.1M | $50.8M | |
Change in Inventories | -$6.5M | -$2.1M | $13.4M | -$1.6M | -$6.3M | |
Cash From Operations | $36.3M | $13.4M | $12.1M | $10.5M | $16.7M | |
Capital Expenditures | $674K | $382K | $511K | $600K | $1.6M | |
Cash Acquisitions | -$178K | -$18M | -- | -- | -- | |
Cash From Investing | -$852K | -$18.4M | -$511K | -$600K | -$1.6M | |
Dividends Paid (Ex Special Dividend) | -$1M | -$1M | -$985K | -$1M | -$996K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $7.8M | $57.4M | $18.4M | $51.5M | $88.9M | |
Long-Term Debt Repaid | -$45.7M | -$63.5M | -$8.7M | -$70.8M | -$95.2M | |
Repurchase of Common Stock | -- | -$671K | -$2.5M | -- | -- | |
Other Financing Activities | -$2.2M | -$568K | -$439K | -$1M | -$416K | |
Cash From Financing | -$40.8M | -$8.2M | $5.7M | -$21.4M | -$7.8M | |
Beginning Cash (CF) | $36M | $28M | $23.6M | $16.2M | $2.9M | |
Foreign Exchange Rate Adjustment | $42K | -$26K | $59K | -$64K | $75K | |
Additions / Reductions | -$5.4M | -$13.1M | $17.3M | -$11.5M | $7.4M | |
Ending Cash (CF) | $30.6M | $14.8M | $41M | $4.6M | $10.4M | |
Levered Free Cash Flow | $35.6M | $13M | $11.6M | $9.9M | $15.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $28.2M | $18.1M | -$15.4M | -$5.9M | -$13.1M | |
Depreciation & Amoritzation | $24.4M | $21.5M | $19.5M | $19.6M | $23.1M | |
Stock-Based Compensation | $6.1M | $4.9M | $3.5M | $3.6M | $4.2M | |
Change in Accounts Receivable | -$43.3M | $15.2M | -$11.9M | $12.2M | $6.5M | |
Change in Inventories | -$42.2M | -$63.1M | $62.9M | $20.5M | -$19.3M | |
Cash From Operations | $47.4M | $14.1M | $23M | $54.8M | $24.8M | |
Capital Expenditures | $1.5M | $3.7M | $3.1M | $2.9M | $3.2M | |
Cash Acquisitions | -$178K | -$14.9M | $21K | -- | -- | |
Cash From Investing | -$1.7M | -$18.6M | -$3.1M | -$2.9M | -$3.2M | |
Dividends Paid (Ex Special Dividend) | -$3.7M | -$3.8M | -$3.8M | -$3.8M | -$3.8M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $70M | $152.9M | $237.3M | $251.5M | $305.6M | |
Long-Term Debt Repaid | -$164.7M | -$159.1M | -$217.1M | -$325.2M | -$317.2M | |
Repurchase of Common Stock | -- | -$671K | -$8.2M | -- | -- | |
Other Financing Activities | -$2.5M | -$1.6M | -$2M | -$10.7M | -$469K | |
Cash From Financing | -$100.8M | -$11.4M | $6.2M | -$88.2M | -$15.9M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$55.1M | -$15.9M | $26.2M | -$36.2M | $5.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $45.9M | $10.4M | $19.9M | $51.9M | $21.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $3.1M | $380K | -$8.8M | -$6.3M | -$4.2M | |
Depreciation & Amoritzation | $6M | $4.9M | $4.9M | $4.9M | $5.7M | |
Stock-Based Compensation | $1.4M | $1.2M | $861K | $807K | $1.1M | |
Change in Accounts Receivable | $39M | $59.7M | $13.9M | $41.1M | $50.8M | |
Change in Inventories | -$6.5M | -$2.1M | $13.4M | -$1.6M | -$6.3M | |
Cash From Operations | $36.3M | $13.4M | $12.1M | $10.5M | $16.7M | |
Capital Expenditures | $674K | $382K | $511K | $600K | $1.6M | |
Cash Acquisitions | -$178K | -$18M | -- | -- | -- | |
Cash From Investing | -$852K | -$18.4M | -$511K | -$600K | -$1.6M | |
Dividends Paid (Ex Special Dividend) | -$1M | -$1M | -$985K | -$1M | -$996K | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | $7.8M | $57.4M | $18.4M | $51.5M | $88.9M | |
Long-Term Debt Repaid | -$45.7M | -$63.5M | -$8.7M | -$70.8M | -$95.2M | |
Repurchase of Common Stock | -- | -$671K | -$2.5M | -- | -- | |
Other Financing Activities | -$2.2M | -$568K | -$439K | -$1M | -$416K | |
Cash From Financing | -$40.8M | -$8.2M | $5.7M | -$21.4M | -$7.8M | |
Beginning Cash (CF) | $36M | $28M | $23.6M | $16.2M | $2.9M | |
Foreign Exchange Rate Adjustment | $42K | -$26K | $59K | -$64K | $75K | |
Additions / Reductions | -$5.4M | -$13.1M | $17.3M | -$11.5M | $7.4M | |
Ending Cash (CF) | $30.6M | $14.8M | $41M | $4.6M | $10.4M | |
Levered Free Cash Flow | $35.6M | $13M | $11.6M | $9.9M | $15.1M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.